Amicus Therapeutics Inc (FOLD)
9.50
-0.09
(-0.94%)
USD |
NASDAQ |
Nov 21, 16:00
9.485
-0.02
(-0.16%)
After-Hours: 20:00
Amicus Therapeutics Max Drawdown (5Y): 74.97% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 74.97% |
| September 30, 2024 | 74.97% |
| August 31, 2024 | 74.97% |
| July 31, 2024 | 74.97% |
| June 30, 2024 | 74.97% |
| May 31, 2024 | 74.97% |
| April 30, 2024 | 74.97% |
| March 31, 2024 | 74.97% |
| February 29, 2024 | 74.97% |
| January 31, 2024 | 74.97% |
| December 31, 2023 | 74.97% |
| November 30, 2023 | 74.97% |
| October 31, 2023 | 74.97% |
| September 30, 2023 | 74.97% |
| August 31, 2023 | 74.97% |
| July 31, 2023 | 74.97% |
| June 30, 2023 | 74.97% |
| May 31, 2023 | 74.97% |
| April 30, 2023 | 74.97% |
| March 31, 2023 | 74.97% |
| February 28, 2023 | 74.97% |
| January 31, 2023 | 74.97% |
| December 31, 2022 | 74.97% |
| November 30, 2022 | 74.97% |
| October 31, 2022 | 74.97% |
| Date | Value |
|---|---|
| September 30, 2022 | 74.97% |
| August 31, 2022 | 74.97% |
| July 31, 2022 | 74.97% |
| June 30, 2022 | 74.97% |
| May 31, 2022 | 74.97% |
| April 30, 2022 | 71.55% |
| March 31, 2022 | 68.30% |
| February 28, 2022 | 67.30% |
| January 31, 2022 | 69.01% |
| December 31, 2021 | 71.86% |
| November 30, 2021 | 75.15% |
| October 31, 2021 | 75.15% |
| September 30, 2021 | 75.15% |
| August 31, 2021 | 75.15% |
| July 31, 2021 | 75.15% |
| June 30, 2021 | 75.15% |
| May 31, 2021 | 75.15% |
| April 30, 2021 | 75.15% |
| March 31, 2021 | 75.15% |
| February 28, 2021 | 75.15% |
| January 31, 2021 | 75.15% |
| December 31, 2020 | 75.15% |
| November 30, 2020 | 75.15% |
| October 31, 2020 | 75.15% |
| September 30, 2020 | 75.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
67.30%
Minimum
Feb 2022
75.15%
Maximum
Nov 2019
74.60%
Average
74.97%
Median
May 2022
Max Drawdown (5Y) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 100.00% |
| Alnylam Pharmaceuticals Inc | 42.46% |
| Ionis Pharmaceuticals Inc | 70.27% |
| Arbutus Biopharma Corp | 95.31% |
| Krystal Biotech Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -4.836 |
| Beta (5Y) | 0.6765 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 51.66% |
| Historical Sharpe Ratio (5Y) | 0.0754 |
| Historical Sortino (5Y) | 0.1261 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.33% |